Atropine Sulfate Ophthalmic Solution
Last Updated: April 25, 2017
Status: Current
Atropine Sulfate Ophthalmic Solution
Products Affected - Description
-
All presentations are currently available
Reason for the Shortage
-
- Alcon has discontinued Isopto Atropine.
- Akorn received FDA approval for atropine sulfate 1% ophthalmic solution in July 2014; this new product launched in January 2015.
- Sandoz has discontinued atropine sulfate ophthalmic solution.
- Valeant discontinued their atropine sulfate 1% ophthalmic solution products in 2015.
Available Products
-
Atropine Sulfate ophthalmic solution, Akorn
1%, 2 mL bottle, 1 count (NDC 17478-0215-02)
1%, 5 mL bottle, 1 count (NDC 17478-0215-05)
1%, 15 mL bottle, 1 count (NDC 17478-0215-15)
1%, 15 mL bottle, 1 count (NDC 17478-0215-15)
Estimated Resupply Dates
-
Akorn has atropine sulfate ophthalmic solution available.
Related Shortages
| Cyclopentolate Hydrochloride and Phenylephrine Hydrochloride Ophthalmic Solution | Resolved |
| Cyclopentolate/phenylephrine Ophthalmic Solution | Resolved |
| Homatropine Hydrobromide Ophthalmic Solution | Resolved |
| Homatropine solution | Resolved No Longer Available |
| Phenylephrine 10% Ophthalmic Solution | Resolved |
| Tropicamide 1% Ophthalmic Solution | Resolved |
Updated
April 25, February 9, 2017; December 12, November 6, September 7, July 20, April 25, March 3, January 28 and 6, 2016; December 22 and 11, September 9, July 20, June 16 and 1, April 20 and 6, February 26 and 4, January 21 and 7, 2015; December 15 and 3, November 21, 2014, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
